CING · Cingulate Inc. Common Stock
View on chartInsiders & Stakes
| GIVENS GREGG WM Director | ▲ Buy | Open Market | 154,318 Shares held | 11/22/2022 | View profile |
| Peter J. Werth Director | ▲ Buy | Open Market | 117,449 Shares held | 2/6/2026 | View profile |
| Thomas Jeffrey Hargroves Director | ▲ Buy | Open Market | 97,468 Shares held | 2/13/2026 | View profile |
| VAN HORN LOUIS G EVP and CFO | ▲ Buy | Open Market | 15,000 Shares held | 3/14/2022 | View profile |
| Jennifer L. Callahan Corporate Controller | ▼ Sell | Tax Withholding | 13,961 Shares held | 3/9/2026 | View profile |
| Gilgallon Craig S. EVP & General Counsel | ▲ Buy | Open Market | 9,550 Shares held | 11/23/2022 | View profile |
| Matthew Brams EVP and Chief Medical Officer | ▼ Sell | Tax Withholding | 8,157 Shares held | 3/9/2026 | View profile |
| Raul R. Silva EVP and CSO | ▼ Sell | Tax Withholding | 4,645 Shares held | 3/9/2026 | View profile |
| Shane J. Schaffer Chief Executive Officer | ▼ Sell | Tax Withholding | 4,076 Shares held | 3/9/2026 | View profile |
| Nilay Dahyabhai Patel EVP, CLO and CCO | ▼ Sell | Tax Withholding | 3,389 Shares held | 3/9/2026 | View profile |
| Myers Laurie EVP and COO | ▼ Sell | Open Market | 0 Shares held | 8/15/2024 | View profile |
| Medeiros Curtis Director | ▼ Sell | Open Market | 0 Shares held | 5/6/2022 | View profile |
Transaction History
| Raul R. Silva | ▲ Buy | Grant | 4,526 | $0 | 3/9/2026 |
| Raul R. Silva | ▼ Sell | Tax Withholding | 1,828 | $0 | 3/9/2026 |
| Shane J. Schaffer | ▲ Buy | Grant | 6,862 | $0 | 3/9/2026 |
| Shane J. Schaffer | ▼ Sell | Tax Withholding | 2,959 | $0 | 3/9/2026 |
| Jennifer L. Callahan | ▲ Buy | Grant | 15,329 | $0 | 3/9/2026 |
| Jennifer L. Callahan | ▼ Sell | Tax Withholding | 6,427 | $0 | 3/9/2026 |
| Nilay Dahyabhai Patel | ▲ Buy | Grant | 5,475 | $0 | 3/9/2026 |
| Nilay Dahyabhai Patel | ▼ Sell | Tax Withholding | 2,086 | $0 | 3/9/2026 |
| Matthew Brams | ▲ Buy | Grant | 4,526 | $0 | 3/9/2026 |
| Matthew Brams | ▼ Sell | Tax Withholding | 1,025 | $0 | 3/9/2026 |
| Thomas Jeffrey Hargroves | ▲ Buy | Open Market | 97,276 | $490K | 2/13/2026 |
| Peter J. Werth | ▲ Buy | Open Market | 19,455 | $98K | 2/6/2026 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 4,864 | $25K | 2/6/2026 |
| Shane J. Schaffer | ▲ Buy | Open Market | 6,809 | $34K | 2/6/2026 |
| Matthew Brams | ▲ Buy | Open Market | 1,946 | $10K | 2/6/2026 |
| Myers Laurie | ▼ Sell | Open Market | 202 | $841 | 8/15/2024 |
| Peter J. Werth | ▲ Buy | Option Exercise | 341,912 | $684 | 4/11/2024 |
| Peter J. Werth | ▲ Buy | Option Exercise | 694,096 | $69 | 4/11/2024 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 5,000 | $3K | 9/15/2023 |
| Peter J. Werth | ▲ Buy | Open Market | 1,823,155 | $1.0M | 8/11/2023 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 2,000 | $2K | 5/15/2023 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 4,000 | $4K | 5/12/2023 |
| Shane J. Schaffer | ▲ Buy | Open Market | 10,000 | $10K | 12/16/2022 |
| Shane J. Schaffer | ▲ Buy | Open Market | 13,267 | $13K | 12/14/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 7,548 | $7K | 12/14/2022 |
| Peter J. Werth | ▲ Buy | Open Market | 28,934 | $28K | 12/13/2022 |
| Shane J. Schaffer | ▲ Buy | Open Market | 1,733 | $2K | 12/13/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 1,530 | $1K | 11/29/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 3,487 | $3K | 11/28/2022 |
| Myers Laurie | ▲ Buy | Open Market | 1,111 | $1000 | 11/23/2022 |
| Gilgallon Craig S. | ▲ Buy | Open Market | 3,575 | $3K | 11/23/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 85,000 | $75K | 11/22/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 3,500 | $5K | 9/8/2022 |
| Peter J. Werth | ▲ Buy | Open Market | 74,500 | $113K | 9/6/2022 |
| Myers Laurie | ▲ Buy | Open Market | 636 | $999 | 9/1/2022 |
| Myers Laurie | ▲ Buy | Open Market | 200 | $236 | 6/1/2022 |
| Myers Laurie | ▼ Sell | Gift | 200 | $0 | 5/24/2022 |
| Myers Laurie | ▲ Buy | Open Market | 200 | $242 | 5/17/2022 |
| Medeiros Curtis | ▼ Sell | Open Market | 17,532 | $22K | 5/6/2022 |
| Peter J. Werth | ▲ Buy | Open Market | 27,000 | $48K | 3/17/2022 |
| Myers Laurie | ▲ Buy | Open Market | 353 | $494 | 3/16/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 1,900 | $3K | 3/16/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 55 | $1K | 3/15/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 27,000 | $37K | 3/15/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 4,000 | $5K | 3/15/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 4,000 | $5K | 3/15/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 4,000 | $6K | 3/15/2022 |
| Medeiros Curtis | ▲ Buy | Open Market | 17,532 | $25K | 3/14/2022 |
| Jennifer L. Callahan | ▲ Buy | Open Market | 12,000 | $17K | 3/14/2022 |
| VAN HORN LOUIS G | ▲ Buy | Open Market | 15,000 | $20K | 3/14/2022 |
| Gilgallon Craig S. | ▲ Buy | Open Market | 5,975 | $8K | 3/14/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 9,000 | $12K | 3/14/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 6,000 | $8K | 3/14/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 6,000 | $8K | 3/14/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 6,000 | $8K | 3/14/2022 |
| GIVENS GREGG WM | ▲ Buy | Open Market | 16,500 | — | 12/10/2021 |
| Shane J. Schaffer | ▲ Buy | Open Market | 16,500 | — | 12/10/2021 |
| Peter J. Werth | ▲ Buy | Open Market | 8,300 | — | 12/10/2021 |
| Thomas Jeffrey Hargroves | ▲ Buy | Open Market | 8,300 | — | 12/10/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CING noted among health-care stocks with pre-market movement
CING was included in a Benzinga list of twelve health-care stocks that showed activity in the pre-market session on Tuesday. The mention suggests some early-day interest in the stock. The shares are currently near a support level of $5.03 and the RSI of 42.2 indicates modest momentum.
CING noted among health-care stocks with pre-market movement. CING was included in a Benzinga list of twelve health-care stocks that showed activity in the pre-market session on Tuesday. The mention suggests some early-day interest in the stock. The shares are currently near a support level of $5.03 and the RSI of 42.2 indicates modest momentum.